Immunocamouflage of latex surfaces by grafted methoxypoly(ethylene glycol) (mPEG): Proteomic analysis of plasma protein adsorption

Science China Life Sciences

Volumn 55, Issue 3, 2012, Pages 191-201

  Le, Yevgeniya ^a,b   Li, Li ^a,b   Wang, Dun Cheng ^a,b   Scott, Mark D ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

immunocamouflage; iTRAQ; mass spectrometry; methoxypoly(ethylene glycol); PEGylation; polymer; polystyrene latex; protein adsorption; proteomics

Indexed keywords

ANTIGEN; BIOMATERIAL; LATEX; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; PLASMA PROTEIN; POLYMER; POLYSTYRENE DERIVATIVE;

ADSORPTION; ARTICLE; BIOPHYSICS; CHEMICAL MODEL; CHEMISTRY; HUMAN; IMMUNE SYSTEM; MASS SPECTROMETRY; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; SURFACE PROPERTY;

ADSORPTION; ANTIGENS; BIOCOMPATIBLE MATERIALS; BIOPHYSICS; BLOOD PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNE SYSTEM; LATEX; MASS SPECTROMETRY; MODELS, CHEMICAL; POLYETHYLENE GLYCOLS; POLYMERS; POLYSTYRENES; PROTEOMICS; SURFACE PROPERTIES;

EID: 84859781481     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-012-4290-2     Document Type: Article

References (35)

1. Gallagher W M, Lynch I, Allen L T, et al. Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies. Biomaterials, 2006, 27: 5871-5882.
2. Ratner B D, Bryant S J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng, 2004, 6: 41-75.
3. Chen A M, Scott M D. Current and future applications of immunological attenuation via pegylation of cells and tissue. BioDrugs, 2001, 15: 833-847.
4. Chen A M, Scott M D. Comparative analysis of polymer and linker chemistries on the efficacy of immunocamouflage of murine leukocytes. Artif Cells Blood Substit Immobil Biotechnol, 2006, 34: 305-322.
5. Scott M D, Murad K L, Koumpouras F, et al. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci USA, 1997, 94: 7566-7571.
6. Sutton T C, Scott M D. The effect of grafted methoxypoly(ethylene glycol) chain length on the inhibition of respiratory syncytial virus (RSV) infection and proliferation. Biomaterials, 2010, 31: 4223-4230.
7. Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227: 680-685.
8. Ross P L, Huang Y N, Marchese J N, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics, 2004, 3: 1154-1169.
9. Vroman L. Effect of absorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature, 1962, 196: 476-477.
10. Horbett T A. Mass action effects on competitive adsorption of fibrinogen from hemoglobin solutions and from plasma. Thromb Haemost, 1984, 51: 174-181.
11. Harris J M. Introduction to biotechnical and biomedical applications of poly(ethylene glycol). In: Harris M J, ed. Topics in Applied Chemistry. New York: Plenum Press, 1992. 1-14.
12. Andrade J D. Interfacial phenomena and biomaterials. Med Instrum, 1973, 7: 110-119.
13. Bradley A J, Murad K L, Regan K L, et al. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim Biophys Acta, 2002, 1561: 147-158.
14. Murad K L, Mahany K L, Brugnara C, et al. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood, 1999, 93: 2121-2127.
15. Bradley A J, Test S T, Murad K L, et al. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion, 2001, 41: 1225-1233.
16. Scott M D, Chen A M. Beyond the red cell: pegylation of other blood cells and tissues. Transfus Clin Biol, 2004, 11: 40-46.
17. Bradley A J, Scott M D. Separation and purification of methoxypoly(ethylene glycol) grafted red blood cells via two-phase partitioning. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 807: 163-168.
18. Bradley A J, Scott M D. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Am J Hematol, 2007, 82: 970-975.
19. Murad K L, Gosselin E J, Eaton J W, et al. Stealth cells: prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood, 1999, 94: 2135-2141.
20. Chen A M, Scott M D. Immunocamouflage: prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells. J Biomed Mater Res A, 2003, 67: 626-636.
21. Scott M D, Murad K L. Cellular camouflage: fooling the immune system with polymers. Curr Pharm Des, 1998, 4: 423-438.
22. McCoy L L, Scott M D. Broad-spectrum antiviral porphylaxis: inhibition of viral infection by polymer grafting with methoxypoly(ethylene glycol). In: Torrence P F, ed. Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats. New York: John Wiley & Sons, Inc., 2005. 379-395.
23. Szleifer I. Protein adsorption on surfaces with grafted polymers: a theoretical approach. Biophys J, 1997, 72: 595-612.
24. Hermans J. Excluded-volume theory of polymer-protein interactions based on polymer chain statistics. J Chem Phys, 1982, 77: 2193-2203.
25. Brooks D E, Haynes C A, Hritcu D, et al. Size exclusion chromatography does not require pores. Proc Natl Acad Sci USA, 2000, 97: 7064-7067.
26. Yasmeen D, Ellerson J R, Dorrington K J, et al. The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1. J Immunol, 1976, 116: 518-526.
27. Colomb M, Porter R R. Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement. Biochem J, 1975, 145: 177-183.
28. Reid K B. Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem J, 1979, 179: 367-371.
29. Lawler J, Duquette M, Urry L, et al. The evolution of the thrombospondin gene family. J Mol Evol, 1993, 36: 509-516.
30. Miyakis S, Giannakopoulos B, Krilis S A. Beta 2 glycoprotein I-function in health and disease. Thromb Res, 2004, 114: 335-346.
31. Brighton T A, Hogg P J, Dai Y P, et al. Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol, 1996, 93: 185-194.
32. Doyen V, Rubio M, Braun D, et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med, 2003, 198: 1277-1283.
33. Li Z, He L, Wilson K, et al. Thrombospondin-1 inhibits TCRmediated T lymphocyte early activation. J Immunol, 2001, 166: 2427-2436.
34. Fleischer J, Grage-Griebenow E, Kasper B, et al. Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J Immunol, 2002, 169: 770-777.
35. Ehlert J E, Ludwig A, Grimm T A, et al. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein. Blood, 2000, 96: 2965-2972.